Health Innovation Wessex (HIW) has launched a Real World Evaluation (RWE) Competition which is open to innovators in health and social care. This competition will award real world evaluations that will be delivered by the Health Innovation Wessex Insight team, at no cost to the innovators. Funding is available to award two real world evaluations.
Undertaking real world evaluation (RWE) of the impact of an innovation, and its implementation in practice, is a vital part of the pathway towards adoption-readiness for a health innovation. Health innovation networks are commissioned by the Office for Life Sciences (OLS) to support economic growth in the health and life science sectors. Even once an innovation can demonstrate that it functions, the adoption needed to support economic growth is often limited by evidence of impact. A real-world evaluation can fill this gap.
Innovators must meet the eligibility criteria, have a clear purpose for an RWE, demonstrate their readiness to undertake evaluation, and demonstrate that they could benefit in terms of commercial growth because of HIW’s support. For full details of eligibility and selection criteria, please see the ‘Guide for Applicants’ under resources on this page. If some RWEs remain unallocated after the initial launch, the call will remain open until two suitable RWEs have been awarded.
"Working with the HIW team throughout the RWE has been a very positive experience. The outcomes of the RWE were everything we could have hoped for, expertly & independently highlighting the transformative potential of our product." Paul Whittle, Market Access Manager, Pentax Medical
| Health Innovation Wessex has not previously evaluated your innovation |
Applicant has an agreed NHS or social care site(s) (i.e. the NHS or social care site that will host the evaluation), evidenced by a letter of support from the site(s). Please email the letter of support to insight@hiwessex.net |
The innovation responds to a recognised or recognisable problem, with likelihood of impact in an NHS or social care setting, and evidence that this impact is desirable to users and stakeholders |
Innovator has a well-defined value proposition for the target market, including the payor’s identity and clarity that the innovation is commissionable in the target setting |
Regulatory approvals are in place* for use in the UK in the clinical application chosen for the evaluation, evidenced by PARD entry check and review of UKCA/CE Declaration of Conformity |
| *If not a regulated product, then there is evidence of efficacy and safety in the target setting/population. If HIW has any doubt about regulatory eligibility, then we will request to see a letter on file from the Medicines and Health care products Regulatory Agency (MHRA) or a medical device regulatory specialist confirming that the system does not fall within the definition of a medical device |
If applying with a digital technology:
|
Innovator has the corporate resources and structure to support implementation in an NHS and/or social care setting |
Innovator and the NHS/social care site has resources and capacity to support implementation, evaluation co-design activities, and governance processes |
Innovator has an implementation plan in place or in development with an understanding of stakeholders and pathway changes required for successful implementation, and likely barriers to be expected |
The RWE can complete by end of March 2025. |
Innovator and evaluation partner (i.e. NHS or social care site) are willing to work with HIW’s communications team to capture your experiences of the RWE as a case study and/or testimonial, and with HIW’s Insight team to support the dissemination of our findings from the RWE. |
We recommend that you download this PDF copy of the expression of interest form and work through your answers before completing the form online, as it is not possible to save your progress.
| RWE Competition launches | 03 September 2024 |
| Deadline for first-call applications | 09:00 on 18 September |
| Selection meetings | w/c 23 September |
| RWE co-design activities commence | October |
| Call repeated | October/November 2024 |
| Call closes | When the two RWEs have been allocated, or 31 Dec 2024, depending on which is soonest |
